AstraZeneca aims to offset drug setback at big cancer congress

Print pagePDF pageEmail page

LONDON (Reuters) – After last month’s big clinical trial setback in lung cancer, AstraZeneca will seek to rebuild its oncology reputation next week when it unveils full details of two key clinical trials tackling the disease in different ways.


Reuters: Health News … More ادامه مطلب

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.